TNFAIP3 mutation is an independent poor overall survival factor for patients with T‐cell acute lymphoblastic leukemia

Abstract

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

BCL11B Mutations Are Associated with Higher CD8+ T-Cell Percentage and Favorable Clinical Outcomes in Patients with T-Cell Acute Lymphoblastic Leukemia

“… 3 Our previous studies have explored the prognostic value of genetic alterations in patients with T-ALL. 5 However, high heterogeneity has led to difficulty in accurately stratifying all patients with T-ALL. Therefore, further exploration of novel biomarkers related to gene mutations is needed to improve the risk stratification for patients with T-ALL.…”